Ramakrishna Chintha

Jodas is a global, specialty, innovation-driven, emerging, generic pharmaceutical company, that is asserting itself among the world’s foremost pharmaceutical companies. We began our journey of growth in the year 2008 in India, and today Jodas is a modern, research-driven organization that has quality and affordability at the heart of its activities. Our Core Therapeutic Segments: Anti Infectives (Injectables) Anti Cancer (Injectables & Orals) Contrast Media – Injectables Critical Care (Injectables & Orals) Our dedicated team of healthcare professionals strives to bring specialty, high-quality, effective, and affordable generic formulations to the market, touching millions of lives with good health. Jodas has approved products in 30+ countries with State-of-the-art world-class manufacturing facilities and has successfully commercialized 19.4 million Injectables in the year 2022, with unparalleled customer satisfaction. The future endeavor is to be a Global generic player, validating our commitment “ONE STEP BETTER”, to fulfill the unmet medical needs of the healthcare community around the Globe with specialty generic formulations of uncompromising quality.